Kymera is a clinical stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system.
Sutro Biopharma
3 followers
Active Motif
3 followers
Dyno Therapeutics
4 followers
Janux Therapeutics
1 follower
Eikon Therapeutics
3 followers
Gilead Sciences
163 followers
Regeneron
135 followers
Illumina
79 followers
Agilent Technologies
85 followers
Verily Life Sciences
46 followers
Alexion Pharmaceuticals
45 followers
Explore companies